Who Owns UNCY?

Unicycive Therapeutics, Inc. — Institutional Ownership & 13F Holdings

$7.19

-0.04 (-0.55%)

Market Cap

$151.5M

Shares Outstanding

21,491,400

Institutional Holders

29

Total Inst. Value

$39.8M

% of Float Held

QoQ Holder Change

+9

Institutional data as of Q1 2025

New Positions

5

Closed Positions

5

Increased

10

Decreased

9

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Octagon Capital Advisors LP$11.1M904,000
2Vivo Capital, LLC$6.5M11,370,152
3GREAT POINT PARTNERS LLC$6.3M10,980,000
4Nantahala Capital Management, LLC$5.4M9,391,994
5Logos Global Management LP$2.9M5,078,927
6Walleye Capital LLC$2.4M4,094,256
7SILVERARC CAPITAL MANAGEMENT, LLC$1.4M2,413,489
8ACUTA CAPITAL PARTNERS, LLC$1.4M2,352,887
9Alyeska Investment Group, L.P.$1.0M1,750,000
10VANGUARD GROUP INC$697K1,212,441

Biggest Buyers & Sellers This Quarter

Top Buyers

Related Stocks

Frequently Asked Questions

How many institutional investors hold UNCY?

As of Q1 2025, 29 institutional investors report holding UNCY (Unicycive Therapeutics, Inc.) in their 13F filings.

Which hedge fund owns the most UNCY?

The largest institutional holder of UNCY is Octagon Capital Advisors LP with $11.1M in shares.

Are institutions buying or selling UNCY?

This quarter, 5 institutions opened new positions in UNCY and 5 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.